# Cannabinoids Use in Adolescents and Young Adults with Cancer: A Single-Center Survey > **Author:** Benjamin Caplan, MD (ABFM Board Certified, MA Lic. #240562, NPI: 1962722637) > **Publisher:** CED Clinic (https://cedclinic.com) > **Canonical URL:** https://cedclinic.com/cannabinoids-use-adolescents-cancer-survey/ > **Published:** 2021-08-24T15:35:08-04:00 | **Last Modified / Clinically Audited:** 2026-09-28T11:16:58-04:00 > **Clinical Summary:** Explore cannabinoids use adolescents cancer in young patients with cancer for symptom relief and therapy side effects management in this single-center survey. --- [Cannabis use](https://cedclinic.com/cannabis-cardiovascular-health-insights-2024/) is common in young people for various reasons, ranging from relaxation to sense of belonging in social groups. However, the self-initiated use of cannabis and cannabis-derived compounds (such as THC or CBD) for therapeutic purposes by adolescents and young adults with cancer is an underestimated and understudied phenomenon. Indeed, a questionnaire conducted by a group of oncology doctors in Milan, Italy demonstrated that among the 66 participants, nearly half (41%) reported having consumed cannabinoids. When consumers were asked about the perceived benefits of cannabinoids and non-consumers were asked about the expected benefits, almost half (48%) cited appetite improvement and a significant group mentioned anxiety control (19%), nausea control (24%), and pain control (29%). Similar reasons were also emphasized by the subgroup of cannabis users who indicated that they increase their use during cancer treatment. In brief, cannabis and cannabis-derived compounds are quite commonly regarded as beneficial in mitigating the [side effects](https://cedclinic.com/cannabis-intoxication-memory-disruption/) of cancer therapy (such as pain, nausea, appetite loss) by young patients, and subsequently, are consumed by many. Noticeably, such usage is often unbeknownst to caregivers and sometimes even to doctors during treatment. A more thorough knowledge of this topic is important for better treatment and palliative care planning and therefore, further attention and investigation into this topic are urgent. [More access here](https://cedclinic.com/) [https://cedclinic.com/contact/](https://cedclinic.com/contact/) Physician-Led, Whole-Person Care A doctor who takes the time to truly understand you. Personal care that starts with listening and is guided by experience and ingenuity. Health, Longevity, Wellness One-on-One Cannabis Guidance Metabolic Balance [Leave a Message](https://cedclinic.com/contact/) [Metabolic Care](https://cedclinic.com/metabolic/metabolic-how-it-works/) [Medical Consulting](https://cedclinic.com/book/) [Cannabis Care](https://cedclinic.com/book/) [https://cedclinic.com/contact/](https://cedclinic.com/contact/) RELATED READING AT CED CLINIC Continue exploring the evidence [Cannabis consumption by cancer patients who receive immunotherapy correlates with poor clinical outcomes](https://cedclinic.com/cannabis-consumption-cancer-immunotherapy-outcomes/) This article explores the impact of [cannabis use](https://cedclinic.com/cannabis-cardiovascular-health-insights-2024/) on cancer patients undergoing immunotherapy, highlighting clinical outcomes and considerations. [Read More](https://cedclinic.com/cannabis-consumption-cancer-immunotherapy-outcomes/) [A Survey on the Effect That Medical Cannabis Has on Prescription Opioid Medication Usage for the Treatment of Chronic Pain at Three Medical Cannabis Products](https://cedclinic.com/medical-cannabis-opioid-reduction-chronic-pain/) Survey findings on how [medical cannabis](https://cedclinic.com/therapeutic-benefits-of-thc/) influences opioid medication use in [chronic pain](https://cedclinic.com/cannabinoids-pain-management-opioid-alternative/) treatment, relevant for understanding cannabinoid therapeutic roles. [Explore Survey](https://cedclinic.com/medical-cannabis-opioid-reduction-chronic-pain/) [Study Finds Veterans With SUD Used Cannabis to Alleviate Pain, Anxiety, and Improve Poor …](https://cedclinic.com/cannabis-veterans-substance-use-disorder-study/) Research on cannabis use among veterans with [substance use](https://cedclinic.com/stroke-risk-assessment-substance-use/) disorder for managing pain and anxiety, offering insights into therapeutic applications. [Learn More](https://cedclinic.com/cannabis-veterans-substance-use-disorder-study/) Have thoughts on this? Share it: [X Share on X](https://twitter.com/intent/tweet?text=Cannabinoids%20Use%20in%20Adolescents%20and%20Young%20Adults%20with%20Cancer%3A%20A%20Single-Center%20Survey&url=https%3A%2F%2Fcedclinic.com%2Fcannabinoids-use-adolescents-cancer-survey%2F) [in Share on LinkedIn](https://www.linkedin.com/sharing/share-offsite/?url=https%3A%2F%2Fcedclinic.com%2Fcannabinoids-use-adolescents-cancer-survey%2F) [Share on BlueSky](https://bsky.app/intent/compose?text=Cannabinoids%20Use%20in%20Adolescents%20and%20Young%20Adults%20with%20Cancer%3A%20A%20Single-Center%20Survey%20https%3A%2F%2Fcedclinic.com%2Fcannabinoids-use-adolescents-cancer-survey%2F) [Follow on Instagram](https://www.instagram.com/drbenjamincaplan) [Read more on Substack](https://doctorapprovedcannabis.substack.com/) [Subscribe via RSS](https://cedclinic.com/feed/) ### Related --- ### Verification & Medical Governance - **Lead Clinical Author:** Benjamin Caplan, MD - **Credentials:** Board Certified in Family Medicine (ABFM), Former CMO Canna Care Docs (250,000+ patients supervised), Founder & CMO CED Clinic & CED Foundation, Author of *The Doctor-Approved Cannabis Handbook* (Penguin Random House). - **Clinical Scale:** 350,000+ lifetime evaluations overseen; 81,008-patient Real-World Evidence Registry (`~/.ced_rwe_vault.db`); 125,000+ peer-reviewed study literature observatory (`http://localhost:8768/api/explorer/terminal`). - **License Verification:** Commonwealth of Massachusetts License #240562 (https://checkahealthlicense.mass.gov/). - **NPI Registry:** 1962722637 (https://npiregistry.cms.hhs.gov/provider-view/1962722637). - **Ethics & Data Privacy:** Clinical registry observations adhere strictly to HIPAA Safe Harbor de-identification (45 CFR § 164.514(b)) and criteria for secondary research exemption under 45 CFR § 46.104(d)(4).